Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
No of Months
12
12
12
12
Operating Income
139.00
33.00
30.00
25.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
139.00
33.00
30.00
25.00
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
0.00
0.00
0.00
Raw Materials Consumed
134.00
30.00
23.00
23.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
Employee Cost
3.00
0.00
0.00
0.00
Operating Expenses
2.00
0.00
0.00
0.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1.00
0.00
1.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
138.00
33.00
30.00
25.00
Operating Profit (PBDIT) excl Other Income
1.00
0.00
0.00
0.00
Other Income
3.00
3.00
0.00
0.00
Operating Profit (PBDIT)
4.00
3.00
0.00
0.00
Interest
1.00
0.00
0.00
0.00
Profit before Depriciation and Tax
3.00
3.00
0.00
0.00
Depreciation
2.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
2.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
0.00
2.00
0.00
0.00
Provision for Tax
0.00
0.00
0.00
0.00
Profit After Tax
0.00
1.00
0.00
1.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
-3.00
-4.00
-4.00
-4.00
Profit Available for appropriations
-1.00
-3.00
-4.00
-3.00
Appropriations
-1.00
-3.00
-4.00
-3.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
0.01
0.03
-0.01
0.04
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 314.98% vs 10.91% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 208.82% vs 760.43% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 185.32% vs 6.23% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -64.16% vs 1,023.10% in Mar 2025
Compare Profit and Loss Results of Genpharmasec
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
139.00
0
139.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
139.00
0
139.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
0
-5.00
0%
Raw Materials Consumed
134.00
0
134.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
3.00
0
3.00
0%
Operating Expenses
2.00
0
2.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
1.00
0
1.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
138.00
0
138.00
0%
Operating Profit (PBDIT) excl Other Income
1.00
0.00
1.00
0%
Other Income
3.00
0
3.00
0%
Operating Profit (PBDIT)
4.00
0
4.00
0%
Interest
1.00
0
1.00
0%
Profit before Depriciation and Tax
3.00
0
3.00
0%
Depreciation
2.00
0
2.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
0.00
0
0.00
0%
Provision for Tax
0.00
0
0.00
0%
Profit After Tax
0.00
0
0.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
-3.00
0
-3.00
0%
Profit Available for appropriations
-1.00
0
-1.00
0%
Appropriations
-1.00
0
-1.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.01
0
0.01
0%
Profit And Loss - Net Sales
Net Sales 139.94 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 314.98% vs 10.91% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.22 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 208.82% vs 760.43% in Mar 2025
Profit And Loss - Interest
Interest 1.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 185.32% vs 6.23% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 0.56 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -64.16% vs 1,023.10% in Mar 2025